With every major election, particularly one that secures or fortifies Republican control of the White House, Senate, or House of Representatives, a certain amount of worry and strategy realignment is to be expected from public health activists and civil society…
The 21st Century Cures Act and a right-wing war on regulations are direct threats to FDA evidentiary requirements for drugs, biologics, and devices By Tim Horn and Suraj Madoori What could possibly be wrong with legislation beamishly called the 21st…
Lingering Republican threats to the ACA and Medicaid do no favors for America’s working poor By Annette Gaudino The 2016 election is in large part a story of the failure of existing health policy to adequately address a health…
Trump’s early tough talk on drug pricing is now a pro-industry, anti-regulation GOP dreamscape By Bryn Gay Unaffordable drug prices were a hot-button topic on the 2016 U.S. presidential campaign trail and remain a significant source of frustration among Democrats…
Mobilizing to defend biomedical research investments and scientific integrity as essential for public health, safety, and well-being By Kenyon Farrow and Mike Frick One of the more memorable moments of resistance to the Trump administration’s and GOP-controlled Congress’ plan to…
Maintaining and expanding the accomplishments of the past depend on a fight for their survival and growth—now more than ever By Mark Harrington Today’s political situation with respect to the struggle to end HIV/AIDS, to treat all of those infected,…
Health, Human Rights, and Social Justice: maximizing HIV, tuberculosis (TB), and viral hepatitis outcomes depends on the availability of state-of-the-art diagnostic and prognostic tools, engagement in expert and supportive care, and access to safe and effective drugs.
We will not end HIV as an epidemic without the expertise and leadership of Black and Latino gay and bisexual men and transgender people of color. By Jeremiah Johnson In February 2016, the CDC issued a new report with a…
Effective responses to the burgeoning hepatitis C pandemic requires solidarity between the global North and South By Bryn Gay We can now cure the hepatitis C virus (HCV) with a coformulation of drugs that yields sustained virologic responses for all…
We can’t end the viral hepatitis epidemics unless we end the war on drug users By Annette Gaudino “Unidentified Filipino male. Unidentified Filipino male. Unidentified Filipino female. Unidentified Filipino male…” It takes a long time to read 1,900 names, long…